SK121394A3 - Agent for prevention and method of its preparation - Google Patents

Agent for prevention and method of its preparation Download PDF

Info

Publication number
SK121394A3
SK121394A3 SK1213-94A SK121394A SK121394A3 SK 121394 A3 SK121394 A3 SK 121394A3 SK 121394 A SK121394 A SK 121394A SK 121394 A3 SK121394 A3 SK 121394A3
Authority
SK
Slovakia
Prior art keywords
myopia
compound
formula
treatment
pharmaceutical composition
Prior art date
Application number
SK1213-94A
Other languages
English (en)
Slovak (sk)
Inventor
Toshiro Shigemitsu
Noriko Watanabe
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of SK121394A3 publication Critical patent/SK121394A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK1213-94A 1993-10-07 1994-10-06 Agent for prevention and method of its preparation SK121394A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25138393 1993-10-07
JP1253794 1994-02-04

Publications (1)

Publication Number Publication Date
SK121394A3 true SK121394A3 (en) 1995-07-11

Family

ID=26348167

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1213-94A SK121394A3 (en) 1993-10-07 1994-10-06 Agent for prevention and method of its preparation

Country Status (18)

Country Link
US (1) US5519030A (de)
EP (1) EP0647445B1 (de)
KR (1) KR100193406B1 (de)
CN (1) CN1108095A (de)
AT (1) ATE175350T1 (de)
AU (1) AU677860B2 (de)
BR (1) BR9404007A (de)
CA (1) CA2133805A1 (de)
CZ (1) CZ244994A3 (de)
DE (1) DE69415757T2 (de)
ES (1) ES2126039T3 (de)
FI (1) FI944687A (de)
HU (1) HUT71112A (de)
NO (1) NO943749L (de)
NZ (1) NZ264616A (de)
PL (1) PL305352A1 (de)
SK (1) SK121394A3 (de)
TW (1) TW282471B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980008226A (ko) * 1996-07-05 1998-04-30 다케다 쿠니오 시각기능장애의 예방 및 치료제
SE0002211D0 (sv) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia
MD38Z5 (ro) * 2009-02-20 2010-02-28 Татьяна ГИДИРИМСКИЙ Metodă de corecţie a vederii la slab văzători
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP2739252A4 (de) 2011-08-05 2015-08-12 Forsight Vision4 Inc Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
AU2014236455B2 (en) 2013-03-14 2018-07-12 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
BR112017002466A2 (pt) * 2014-08-08 2017-12-05 Forsight Vision4 Inc formulações estáveis e solúveis de inibidores da tirosina cinase do receptor, e métodos para a sua preparação

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JPH06110587A (ja) * 1992-09-28 1994-04-22 Omron Corp 自動取引き機の電源制御方法とその装置

Also Published As

Publication number Publication date
EP0647445A1 (de) 1995-04-12
KR100193406B1 (ko) 1999-06-15
KR950010896A (ko) 1995-05-15
BR9404007A (pt) 1995-06-13
CZ244994A3 (en) 1995-04-12
ES2126039T3 (es) 1999-03-16
NZ264616A (en) 1997-06-24
DE69415757T2 (de) 1999-06-10
HUT71112A (en) 1995-11-28
FI944687A0 (fi) 1994-10-06
CN1108095A (zh) 1995-09-13
DE69415757D1 (de) 1999-02-18
EP0647445B1 (de) 1999-01-07
HU9402883D0 (en) 1995-01-30
AU677860B2 (en) 1997-05-08
CA2133805A1 (en) 1995-04-08
TW282471B (de) 1996-08-01
NO943749L (no) 1995-04-10
AU7441794A (en) 1995-04-27
FI944687A (fi) 1995-04-08
NO943749D0 (no) 1994-10-06
US5519030A (en) 1996-05-21
ATE175350T1 (de) 1999-01-15
PL305352A1 (en) 1995-04-18

Similar Documents

Publication Publication Date Title
AU2003297511B2 (en) Ophthalmic formulation for the prevention and treatment of ocular conditions
EP1904108B1 (de) Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin
US7875271B2 (en) Ophthalmic composition comprising xanthan gum and glucose
KR100253515B1 (ko) 녹내장 치료용 의약 조성물
SK147493A3 (en) Antialergic substances for the use in ophthalmologic and otorhynologic
EA013931B1 (ru) Способ лечения глазных расстройств
US6403598B1 (en) Ophthalmic composition
AU673533B2 (en) Pharmaceutical composition
SK121394A3 (en) Agent for prevention and method of its preparation
JP3527256B2 (ja) 抗アレルギー点眼剤
Gunning et al. Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study
CA2055434A1 (en) Paracetamol-based pharmaceutical composition
JP3066561B2 (ja) 近視予防・治療剤
JPH11279062A (ja) 眼科用剤
CA2187361A1 (en) Pharmaceutical composition for treating glaucoma containing terazosin
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物
JP2741285B2 (ja) 緑内障治療剤
CZ20002770A3 (cs) Oční prostředky